Prognostic Effect of Comorbidities Among Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Second Generation Tyrosine Kinase Inhibitors: A Five-Year Retrospective Study
Venessa S. Ediza MD¹ , Anne Kristine H. Quero-Taggaoa,MD²
Contact: vanediza08@gmail.com